At the same time, another study demonstrated that TRIM27 could induce colitis to promote the tumorigenesis of colitis-associated cancer by recruiting gp130 and JAK1 to activate the IL6-STAT3 signaling pathway (Zhang H. X. et al., 2018). Here, JAK1 is linked to colitis.